CAROL PURCELL: Open Payments
NPI 1043336126 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,188 in 110 payments from 15 companies in 2025. Trend: 2023 $1,901 · 2024 $1,914 · 2025 $2,188
Food & beverage: $2,088Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $526 |
| Incyte Corporation | 34 | $369 |
| Janssen Biotech, Inc. | 13 | $368 |
| ABBVIE INC. | 22 | $282 |
| GENZYME CORPORATION | 8 | $200 |
| Amgen Inc. | 6 | $120 |
| Lilly USA, LLC | 3 | $64 |
| LEO Pharma Inc. | 1 | $52 |
| UCB, Inc. | 2 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $34 |
Products named: OPZELURA, TREMFYA, SKYRIZI, DUPIXENT, Rhapsido, OTEZLA, COSENTYX, ANZUPGO.
Industry payments across NM — which companies pay providers there.
